Wells Fargo & Company Turning Point Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$24.32 - $75.3 $3.63 Million - $11.2 Million	-149,142 Reduced 94.57%	8,569 $645,000
Q1 2022 May 16, 2022	SELL	$24.73 - $51.25 $29,774 - $61,705	-1,204 Reduced 0.76%	157,711 $4.24 Million
Q4 2021 Feb 14, 2022	SELL	$35.48 - $67.33 $17.1 Million - $32.4 Million	-481,234 Reduced 75.18%	158,915 $7.58 Million
Q3 2021 Nov 15, 2021	SELL	$61.0 - $81.99 $429,135 - $576,799	-7,035 Reduced 1.09%	640,149 $42.5 Million
Q2 2021 Aug 16, 2021	BUY	$62.93 - $90.59 $506,397 - $728,977	8,047 Added 1.26%	647,184 $50.5 Million
Q1 2021 May 13, 2021	BUY	$88.19 - $140.01 $673,507 - $1.07 Million	7,637 Added 1.21%	639,137 $60.5 Million
Q4 2020 Feb 09, 2021	BUY	$87.69 - $130.94 $1.82 Million - $2.72 Million	20,766 Added 3.4%	631,500 $76.9 Million
Q3 2020 Nov 05, 2020	BUY	$56.99 - $89.33 $6.22 Million - $9.74 Million	109,081 Added 21.74%	610,734 $53.4 Million
Q2 2020 Aug 13, 2020	BUY	$39.94 - $70.39 $416,414 - $733,886	10,426 Added 2.12%	501,653 $32.4 Million
Q1 2020 May 14, 2020	BUY	$32.02 - $66.17 $15.7 Million - $32.5 Million	491,227 New	491,227 $21.9 Million

About Turning Point Therapeutics, Inc.

Ticker TPTX
Exchange NASDAQ
Shares Outstandng 50,074,300

More about TPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.